Products

BioMarin has developed and commercialized four products since 1997, a remarkable accomplishment in the biopharmaceutical industry, and a testament to the company’s passion and dedication to patients with serious, unmet medical needs.

Products on the Market

BioMarin has four marketed products on the market today:

• Kuvan^® (sapropterin dihydrochloride) Tablets for PKU
• Naglazyme^® (galsulfase) for MPS VI
• Aldurazyme^® (laronidase) for MPS I
• Firdapse™(currently approved in the EU only) (amifampridine phosphate) for LEMS

For full prescribing information, please visit www.kuvan.com, www.naglazyme.com, and www.aldurazyme.com.

• Overview
• Naglazyme®
• Aldurazyme®
• Kuvan®
• Firdapse™